Intervention not reported
Change in measures of nutritional status: weight (kg), body mass index (kg/ m2), and waist/ hip ratio (cms) · participants with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis
The review found no eligible studies for this question.
1 finding from 1 review
Change in muscle mass at 12 months (%) ‐ not measured · people with inclusion body myositis
The review found no eligible studies for this question.
1 finding from 1 review
Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis
The review found no eligible studies for this question.
1 finding from 1 review
Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis
The review found no eligible studies for this question.
1 finding from 1 review
Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis
1 finding from 1 review
Change in muscle mass at 6 months (%) ‐ not measured · people with inclusion body myositis
1 finding from 1 review
Intervention not reported
Body mass index, change from baseline (kg/m2) · people with primary prevention of cardiovascular disease in
1 finding from 1 review
Fat mass measured in % of TBW · patients with reducing morbidity and mortality in people with HIV
1 finding from 1 review
Fat free mass · patients with reducing morbidity and mortality in people with HIV
1 finding from 1 review
Body‐mass index (BMI) · Edentulous patients aged 45 to 80 years attending dental-student teaching clinics for replacement dentures, Newcastle Dental Hospital, UK
1 finding from 1 review
Intervention not reported
Fat‐free mass/fat‐free mass index (change from baseline; mixed population) kg/m2 · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Fat‐free mass/fat‐free mass index (change from baseline; undernourished participants) kg/m2 · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Fat mass/fat mass index (change from baseline; undernourished participants) kg/m2 · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Fat‐free mass index (mixed population) kg/m2 · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Fat‐free mass index (undernourished patients) kg/m2 · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Pain on palpation of right masseter muscle (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral clonazepam (benzodiazepine) showed no clear difference in pain on palpation of right masseter muscle (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
Spontaneous masseter muscle pain (numerical graph rating scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Topical methyl salicylate (Theraflex-TMJ) led to lower spontaneous masseter muscle pain (numerical graph rating scale) compared with placebo; GRADE not reported.
1 finding from 1 review
Pain on palpation of left masseter muscle (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral clonazepam (benzodiazepine) showed no clear difference in pain on palpation of left masseter muscle (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
All‐cause mortality(7‐day) · people with intermediate‐risk (submassive) APE
1 finding from 1 review